Creative Enzymes stands as a leading provider of enzyme-related services and solutions. Committed to innovation and excellence, the organization supports research in enzymology and biotechnology by ...

A new wave of antibody-targeted anticancer therapies is showing great clinical promise, with the potential to transform cancer treatment. These antibody-drug conjugates (ADCs) are multicomponent ...

Glycosite-specific conjugation has emerged as a gold standard for developing next-generation Antibody-Drug Conjugates (ADCs) and other XDCs. However, most existing approaches are hindered by ...

Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical and nuclear medicine research.

First developed in 1992, immuno-PCR combines an ELISA (enzyme-linked immunosorbent assay) with PCR (polymerase chain reaction) to offer a significant increase in sensitivity compared with traditional ...

BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody-drug conjugate (ADC) to ...